Overview

Assessment of the Safety and Efficacy of 3VM1001 Cream for Treatment of Chronic Pain Caused by Knee Osteoarthritis.

Status:
Unknown status

Trial end date:
2016-03-01

Target enrollment:

Participant gender:

Summary

3VM1001 is a topical cream that may be useful for the treatment of chronic osteoarthritis of the knee. This proof of concept study is a randomized, placebo-controlled, double-blind study to compare treatment with 3VM1001 cream to an inactive cream placebo. Subjects will self-treat for 30 days.

Phase:

Phase 1

Details

Lead Sponsor:

CDA Research Group, Inc.

Collaborator:

3VM Research Group, Inc.